ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Asia300

Dr. Reddy's posts steeper-than-expected fall in third-quarter profit

One-time charge on U.S. tax liabilities erodes net income

MUMBAI (NewsRise) -- Dr. Reddy's Laboratories, India's second-largest drug maker, reported a bigger-than-expected 29% drop in quarterly net profit, weighed by a one-time charge related to changes in U.S. tax liabilities.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more